. Author manuscript; available in PMC: 2021 Apr 1.

Published in final edited form as: J Vasc Interv Radiol. 2019 Sep 14;31(4):592–597. doi: 10.1016/j.jvir.2019.07.025

Table 1.

Patient characteristics at time of intervention.

	(N=398)
Age, years, Mean (SD)	73.4 (8.6)
Sex
Female	192 (48.2%)
Male	206 (51.8%)
Estimated glomerular filtration rate, Mean (SD), ml/min/1.73m²
6–12 months pre intervention	48.3 (18.7)
At time of intervention	42.5 (17.8)
6–12 months post intervention	45.5 (20.1)
Proteinuria, Mean (SD), mg/24hrs	428.5 (888.1)
Comorbidities, n (%)
Diabetes Mellitus	138 (34.7)
Hypertension	387 (97.0)
Hyperlipidemia	331 (83.2)
Coronary artery disease	267 (67.1)
Statin	320 (80.4)
Medications, n (%)
Angiotensin-converting enzyme inhibitor/Angiotensin II receptor blocker	351 (88.2)
Calcium Channel Blocker	321 (80.7)
Beta Blocker	335 (84.2)
Aspirin	350 (87.9)
Clopidogrel	264 (66.3)
Warfarin	156 (39.2)
Insulin	102 (25.6)